翰森制药 8 款 1 类新药首次获批临床

Insight数据库
11 Jul

Insight数据库显示,2025年以来,翰森制药有8款 1 类新药首次获批临床。从药物类型来看,包括2款ADC、6款化药。从适应症来看,3款药物用于治疗肿瘤、3款用于治疗免疫系统疾病、1款为心血管系统药物、1款为内分泌系统和代谢药物。来源:Insight 数据库整理本文将具体介绍一下已披露靶点的 5 款产品,供参考。HS-10561:BTK 抑制剂2 月 25 日,HS-10561 在国内首次...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10